Scientists have shown how stomach cancers can dodge the effects of a promising new experimental treatment – raising the possibility of outsmarting cancer by predicting drug resistance in advance.

Gastric cancer, also known as stomach cancer, can develop in any part of the stomach and may spread to other areas of the digestive system and beyond. Although global cases have steadily declined ...

Clinicians can help reduce gastric cancer incidence and mortality in high-risk groups through endoscopic screening and surveillance of precancerous conditions, such as gastric intestinal ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today presented data at the American Association for Cancer Research (AACR) IO Annual Meeting ...

Gastric cancer is the fourth leading cause of cancer-related deaths worldwide. Infection with Helicobacter pylori bacteria, whilst asymptomatic for most people, has long been identified as the ...

The clinical trial and a new study mark a significant leap in the fight against gastric cancer with peritoneal spread. Read more at straitstimes.com. Read more at straitstimes.com.

East Asian people are more likely to develop a more aggressive type of stomach cancer because of their higher likelihood of alcohol intolerance, according to a new study led by researchers in Japan.

Oct 18 (Reuters) - The U.S. Food and Drug Administration approved Astellas' (4503.T), opens new tab therapy to treat a type of gastric cancer, the health regulator's website showed on Friday.

"While there have been advances in the first-line treatment of locally advanced unresectable and metastatic gastric and GEJ cancers ... responses that kill the cancer cells. The FDA approval ...